A Swedish-led research team at Karolinska Institutet and Karolinska University Hospital has shown in a new randomized ...

A low dose reduces the likelihood of recurrence in people who have had surgery to remove tumors with a common genetic ...

Icotrokinra is a first-in-class oral peptide drug that selectively inhibits the IL-23 receptor, disrupting IL-23 signaling ...

Overall Survival Analysis of the Phase III CodeBreaK 300 Study of Sotorasib Plus Panitumumab Versus Investigator's Choice in Chemorefractory KRAS G12C Colorectal Cancer This randomized phase Ib ...

Many of the randomized controlled trials for large vessel vasculitis with significant or nonsignificant outcomes show fragility, and measures do not vary with the risk for bias, drug type, or subtype.

A randomized phase 2 peri-operative (neoadjuvant plus adjuvant) study of fianlimab (anti–LAG-3) plus cemiplimab (anti–PD-1) versus anti–PD-1 alone in patients with resectable stage III and IV melanoma ...

Results of a new study support using semaglutide and tirzepatide to reduce risk in patients with cardiometabolic heart ...

Purpose To determine the effects of advanced spectacle lens technologies on changes in spherical equivalent of refraction ...